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Inducible vascular nitric oxide synthasc accounts for the contractile impairment observed in endotoxcmia. WC provide evidence that lipoteichoic 
acid (LTA) from Srupplr,&eoccrts uurees. a micro-organism without endotoxin. also induces nilric oxide synthasc. Our study demonstrates that on 
endothclium-free rings ofra~ aorta, LTAmlike lipopolysaccheridc inducesa loss ofcontractility restored by Mcthylene blucand p-nitro+argininc- 
methyl ester (LNAME). Moreover in cultured vascular smooth muscle cells. LTA produces a dose-dependent increase in intracellular cyclic GMP 
which is antaponired by LNAME and prevented by dcxamcthasone. 
Lipoteichoic acid; Endotoxin: Nitric oxide (NO) synthasc; Cyclic GMP; Rat aorta 
1. 1NTRODUCTlON 
Septic shock results from an infective process induced 
by endotoxins constituting lipopolysaccharide (LPS), 
the major components of the outer membrane of Gram- 
negative bacteria. Circulating levels of endotoxin induce 
haemodynamic alterations including systemic arterial 
hypotension associated wit!1 hypo-responsiveness to 
pressor agents. The observed in vivo vascular hypo- 
responsiveness persists when vascular tissue removed 
from LPS-injected rat is examined ex vivo [l-4] or when 
artery rings are incubated in vitro with LPS [5,6]. It has 
been recently demonstrated inex vivo [7] and in in vitro 
studies [8,9] that the loss of vascular eactivity induced 
by LPS was due to an overproduction of nitric oxide 
(NO). However, if NO synthesis from L-arginine was 
originally discovered in vascular endothelial cells [lCl], 
the vascular smooth muscle cells seem to be the main 
source of NO activated by LPS [7-93. In addition, a 
Ca2’-independent NO synthase that is sensitive to dexa- 
methasone and induced by LPS has been shown in vas- 
cular smooth muscle cells [l 11. 
However, cardiovascular dysfunctions associated 
with septic shock may also be observed in the absence 
of endotoxemia [ 12,131. Similar haemodynamic changes 
are produced either by a Gram-negative bacteria 
(Esctwwkltiu co/i) or by a Gram-positive bacteria (SW 
pizylococcus aweus), a micro-organism without LPS, in- 
dicating a common pathway leading to cardiovascular 
abnormalities [14]. In the present study, we describe the 
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induction of NO synthase in vascular smooth muscle 
cells by lipoteichoic acid (LTA), a component of the 
membrane of Gram-positive bacteria [15]. The results 
suggest hat induction of NO synthase in the vascular 
wall is a general phenomenon responsible for the loss 
of reactivity in bacteremia caused by Gram-positive or 
Gram-negative micro-organisms. 
2. MATERIALS AND METHODS 
2. I. Corifrucfile resporlses b rut uorfic rirtgs 
Endothelium-free rings (2 mm wide) from rat aorta were incubated 
for 5 h in MEM medium. in the absence (control) or presence ofeither 
LPS or LTA. Then, rings were suspended under a tension oT 2 g in 
organ baths containing Krcbs-Hcnseleit solution as previously de- 
scribed [4.7]. After a GO min equilibration period, contraction was 
induced by application of a maximal concentration of phenylcphrine 
(PE. IO PM). 
Smooth muscle cells were isolated by enzymatic (clastase and col- 
lagenasc) digestion of rat thoracic aorta as previously described [l6]. 
They were cultured for 4 days in DMEM with 10% fetal calf serum 
and used between passages 3 and 7. 
Cell monolayers were washed and the medium was replaced with 
2 ml of DMEM containing 2 mM glutamine, antibiotics. 0.1 mM 
isobutylmcthylxanthinc (IBMX) with of without LPS or LTA. After 
24 h. cCiMP was extracted from cells by rapid aspiration of the 
medium and addition of I ml 0.1 N HCI to each well. The samples were 
frozen until cGMP detenination by mdioimmunoassry (NEN kit). 
To study the cl%ct of LNAME.cclls were incubated for 24 h in RPM1 
1640 (Learginine concentration is I 2 mM) with or without LPS (0.1 
pg/ml) or LTA (IO ,udml). IBMX (0.1 mM) was added 30 min before 
cGMP extraction in the presence or not of LNAME (1.2 mM). 
NG-nitro-t_-arginine methyl ester salt was purchased from Calm 
b&hem. Phenylephrinc. dcxamcthasonc. cndotoxin (lipopolysac- 
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Fig. I. Kinetics of the contraction induced by phcnylcphrine (IOpM) 
on cndothclium~frre ings of rat aorta incubated for 5 h in the presence 
or absence of LPS (IOyM) or LTA (IOpM). LTA was also incubated 
in the prcsuncc of I ,uM dexamethusone (DEXA). Mean f S.E.M. 
Figures in parentheses indicate the number of measurements. 
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2.5, Stutistics 
The data are given as means r S.E.M. and one-way analysis of 
variance (ANOVA) was used for statistical comparison of the results. 
3. RESULTS AND DISCUSSION 
Five hour incubation of endothelium-free rings of rat 
aorta in the presence of LPS (10 pg/ml) induced a loss 
of tonicity to the contractile response of phenylephrine 
(10 PM). This phenomenon has previously been attrib- 
uted to the induction of smooth muscle NO synthase 
by endotoxin [7,9]. Incubation with LTA (10 pug/ml) 
resulted in a comparable decrease in the contraction 
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Fig. 2. The effects of LNAME and Mcthylcne blue (MB) in reversing 
the loss of contraction tonicity to phenylephrine (PE) in cndothelium- 
free rings incubated with LPS or LTA. The drugs were added in a 
dose-dependent manner after IO5 min contraction to PE when con- 
tractile impairment was maximal (see Fig. I). Histograms depict he 
maximal tension induced by phenylephrine. Mean k S.E.M. Figures 
in parentheses indicate the number of measurements. 
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Fig. 3. Dose relationship for the cGMP accumulation i duced by LTA 
in cultured smooth muscle cells. Means + S.E.M. of 3 experiments 
performed in triplicate. 
elicited by phenylephrine (Fig. 1). The loss of vascular 
responsiveness was not observed after 1 h incubation 
with LPS or LTA up to 100 j&ril (n = 3) indicating ;I 
delayed cellular process and suggesting an induction of 
a biological activity. Indeed, the effects of LTA were 
abolished by I yM dexamethasone (Fig, I) which is 
known to prevent the induction of NO synthase by 
endotoxin [9]. Furthermore p-nitro-L-arginine-methyl 
ester (LNAME), a specific inhibitor of NO synthase, 
was equally potent in restoring the contractile defect o 
phenylephrine due to LPS or LTA (Fig. 2). Methylene 
blue was also able to counteract he action of LTA 
indicating the activation of soluble guanylate cyclase 
responsible for the vascular hypo-reactivity (Fig. 3). 
t_-Arginine (300 ,uM) rapidly reversed the effects of 
LNAME (30 ,KM), but not those of Methylene blue (10 
,uM) (data not shown). 
These results were extended in cultured vascular 
smooth muscle cells. Incubation with LPS or LTA ex- 
hibited a time- and dose-dependent elevation in intracel- 
lu!ar cGMP. LPS (from 1 rig/ml to 10 yglml) induced 
an elevation in cGMP content from 0.83 k 0.04 (control 
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Fig. 4. Effect of LNAME (I 2 mM) on cGMP accumulation i smooth 
muscle cells in cultures incubated for 24 h in the presence of 0.1 ygIml 
LPS or IO ,Ug/ml LTA. Means 2 S.E.M. of 3 cxpcrimcnts performed 
in triplicate. “P < 0.01. 
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cells) to a maximal value 40.8 k 5.8 pmol/lO” cells (I 
pg/ml LPS). In the same conditions LTA elicited an 
increase of cGMP production with an ECSo of about 0. I 
Ag/rnl (Fig. 3). The effects of LPS or LTA (0.1 pdrnl) 
were inhibited by 90% in cells which were co-treated 
with dexamethasone (1PM). A 30 min incubation with 
LNAME (1.2 mM) reduced the increased cGMP ac- 
cumulation in both LPS- and LTA-treated cells (Fig. 4). 
These results provide the first evidence that LTA, like 
LPS, expresses NO synthase in vascular smooth muscle 
cells. This indicates that an inducible NO/L-arginine 
pathway may participate to the severe hypotension in- 
duced by sepsis either caused by Gram-positive or 
Gram-negative bacteria. Moreover, our study dem- 
onstrates a direct action of the bacterial membrane 
components LPS and LTA on vascular smooth muscle 
cells. 
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